• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease

    Aural Analytics' Speech Analytics Software for ALS Gains Breakthrough Status

    Bigfoot Biomedical Acquires Insulin Titration Algorithm from McGill

    Apply Now: Junkosha's Technology Innovator of the Year Awards 2023

    SIS Medical's OPN NC PTCA Dilatation Catheter Released in U.S.
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Timeline Mystery for Updated EtO Rules

    An Update on Hospital Trends Post-Pandemic

    Don’t Fear the Audit: Benefits of Good Quality Practices

    Understanding the FDA’s Standards & Conformity Assessment Program

    Medtech Divestitures Are Good for Medtech Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    LEMO USA Inc.

    Providence Enterprise USA Inc.

    Forefront Medical Technology

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Designing for Manufacturing: 5 Common Startup Mistakes (and How to Avoid Them)

    5 Challenges Medtech Must Address to Transform Healthcare

    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    LEMO USA Inc.

    Providence Enterprise USA Inc.

    Forefront Medical Technology

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    LivaNova, Verily Begin Difficult-to-Treat Depression Study

    Verily research tools will evaluate real-world VNS Therapy effectiveness as adjunctive difficult-to-treat depression treatment.

    LivaNova, Verily Begin Difficult-to-Treat Depression Study
    Sam Brusco, Associate Editor04.27.21
    LivaNova and Verily have enrolled the first patient in their collaborative UNCOVER study or “The RECOVER Sub-Study, Which Leverages Quantitative and Credible Research Tools from Verily, Will Provide Assessment Measures for Depressive Episodes.”
     
    UNCOVER is an opt-in research study for patients in the ongoing LivaNova clinical study RECOVER or “A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy as Adjunctive Therapy Versus a No Stimulation Control in Subjects with Treatment-Resistant Depression.” The UNCOVER sub-study deploys technology-enabled research tools from Verily to evaluate VNS Therapy’ real-word efficacy as an adjunctive treatment for difficult-to-treat depression (DTD).
     
    UNCOVER sub-study patients will use two Verily-developed digital tools: a wearable, multi-sensor device (Verily Study Watch) and Android smartphone app (Verily Mood App). The tools measure passive and active data, such as the participant’s pulse rate, activity levels, and sleep quality. The Mood App also allows recording voice diaries to more accurately assess depressive episodes and their effect on daily living.
     
    “After detailed planning with our colleagues at LivaNova, we are pleased to have launched the UNCOVER study and enrolled the first participant,” Dr. William Marks, Head of Clinical Science and Neurology at Verily, told the press. “These Verily tools will collect behavioral, environmental, and physiological data from study participants, with the goal of painting a clearer picture of depressive episodes and the impact depression has on individual’s lives over the course of the study.”
     
    Quantitative data obtained from these Verily tools will supplement the clinical outcomes collected in the RECOVER study, providing clinicians a more comprehensive view of whether each patient’s depression is improving, staying the same, or worsening.
     
    Depression continues to be an important health concern globally and an area in need of more effective treatments. Research shows the number of adults experiencing depression in the U.S. has tripled in recent times. Before the pandemic, 8.5 percent of U.S. adults reported being depressed, whereas that number has risen to 27.8 percent as the country deals with COVID-19.1
     
    “For as many as one in three patients, medication alone may not be enough to combat depression that is difficult to treat,”2 said Damien McDonald, CEO of LivaNova. “As we re-confirm the effectiveness of VNS Therapy in treating depression through the RECOVER study, we hope to learn even more through the UNCOVER sub-study about each patient’s journey and the daily improvements in their lives with the use of Verily tools so we can provide the most effective treatment for this disorder.”
     
    Launched in September 2019, RECOVER is studying up to 1,000 people ages 18 or older with difficult-to-treat depression or bipolar depression. The double-blind, randomized, placebo-controlled study is assessing how VNS Therapy can offer patients relief from their DTD symptoms and improve quality of life. Symmetry, the LivaNova VNS Therapy System for depression, is the first and only FDA-approved implantable device specifically designed for DTD. RECOVER is being carried out at up to 100 leading hospitals and medical centers across the United States. RECOVER subjects from participating sites who own an Android smartphone are being offered the option to participate in the UNCOVER sub-study, with a maximum of 300 subjects to be enrolled. LivaNova and Verily announced their collaboration on UNCOVER in February 2020.
     
    Reference
    1 Ettman, C, Abdalla, S, Cohen G, et al. Prevalence of Depression Symptoms in U.S. Adults Before and During the COVID-19 Pandemic. JAMA Network Open. 2020;3(9):e2019686. doi:10.1001/jamanetworkopen.2020.19686.
    2 STARD: Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–1917. 
     
    Related Searches
    • Neurological
    Related Knowledge Center
    • Neurological
    Suggested For You
    Advanced Powder Products (APP) Advanced Powder Products (APP)
    NTK Cutting Tools USA NTK Cutting Tools USA
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    sfm medical devices GmbH sfm medical devices GmbH
    WESTPAK Inc. WESTPAK Inc.
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions
    High Tech Turning Co. Inc. High Tech Turning Co. Inc.
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    First CellFX Procedure Performed in Canada First CellFX Procedure Performed in Canada
    Turner Imaging Systems Announces International Expansion Turner Imaging Systems Announces International Expansion
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021 MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    Boston Scientific Agrees to Acquire Devoro Medical Boston Scientific Agrees to Acquire Devoro Medical

    Related Buyers Guide Companies

    • Advanced Powder Products (APP)

      Advanced Powder Products (APP)

      ...
      Nicholas Eidem, Advanced Powder Products 11.30.22

    • NTK Cutting Tools USA

      ...
      Melissa Singher, Senior Product Coordinator 11.18.22

    • JK Medirise-Disposable Medical Device Company

      ...
      Ketan Munjani, Marketing Manager 11.17.22


    • sfm medical devices GmbH

      ...
      Albert Busch, Head of Marketing 11.11.22

    • Packaging & Sterilization
      WESTPAK Inc.

      WESTPAK Inc.

      ...
      Tim Eells, WESTPAK, Inc. 03.04.22

    Loading, Please Wait..

    Trending
    • Medinbox And Abbott Partner To Increase Efficiency In Electrophysiology Labs
    • Masimo Reveals Freedom Health-Tracking Smartwatch
    • FDA OKs FemDx Medsystems' FalloView Device
    • Getinge’s Cardiosave Faces CE-Certificate Suspension From TÜV SÜD
    • A New Approach To Post-Market Surveillance
    Breaking News
    • TOTAL Toric Contact Lenses for Astigmatism Debuts in Canada
    • FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
    • Aural Analytics' Speech Analytics Software for ALS Gains Breakthrough Status
    • Bigfoot Biomedical Acquires Insulin Titration Algorithm from McGill
    • Apply Now: Junkosha's Technology Innovator of the Year Awards 2023
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Sensing Technology Drives the Future of Medical Care
    • New and Developing Diabetes Technologies Offer 'Sweet Relief'
    • Discussing Matters of Substance in Medtech Materials
    • Medical Device Testers Are Caught Up in a Whirlwind
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kemin Human Nutrition & Health Acquires Oral Health Ingredient
    Wiley Eliminates Outer Carton From Packaging to Reduce Waste
    ACG Expands as Vantage Nutrition Acquires ComboCap and its Dual-Chamber Capsule Technology
    Coatings World

    Latest Breaking News From Coatings World

    PPG Names Rodolfo Ramirez GM, Packaging Coatings
    Sherwin-Williams Unveils High Performance Interior Marine Decking Systems
    AkzoNobel Appoints Ricardo Rosso as Pontiac Site Manager
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
    Aural Analytics' Speech Analytics Software for ALS Gains Breakthrough Status
    Bigfoot Biomedical Acquires Insulin Titration Algorithm from McGill
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Thermo Fisher, Arsenal Biosciences Partner to Manufacture Autologous T-Cell Therapies
    Aquestive Therapeutics Expands Libervant License/Supply Agreement with Pharmanovia
    OncoVent, Orient EuroPharma Enter License Agreement for Oregovomab
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    GK Launches Vegan Hair Styling Range
    Sexual Wellness Brand Playground Recruits Christina Aguilera
    Buttah Skin Founder Wins Emerging Brand Partner of the Year Award from Macy’s
    Happi

    Latest Breaking News From Happi

    Ichimaru Pharcos Launches HyaluGuard Anti-Aging Ingredient
    Indie Personal Care and Skincare Brand Indigo Wild Mainstreams Geranium-Patchouli Scent
    Kao Launches Space Shampoo Sheet for Haircare
    Ink World

    Latest Breaking News From Ink World

    INX International Makes Investment in Gooten
    Videojet Launches 1580 C Soft-Pigmented Contrast Printer
    Epson to Showcase Textile, Signage and Aqueous Printers at ISA 2023
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    AWA announces first International Linerless Label Conference
    Apex partners with MicroDynamics for anilox quality control
    Industrias Omega adds Durst Tau RSC E
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Toray Awarded for Nanodesign Technology
    SharpCell Launches Plastic-free Airlaid Material for Premium Napkins
    Suominen Offers Biolace Ultrasoft
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    CoreLink's Siber Ti 3D-Printed SI Joint Fusion System Earns FDA Nod
    Collagen Matrix Rebrands to Regenity Biosciences
    OsteoBoost Study Yields Positive Results
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Universal Display Sponsors, Presents at ICDT 2023
    Miron Washington Joins Impinj Board of Directors
    All-Time High for Global 300MM Semiconductor Capacity in 2026: SEMI

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login